---
figid: PMC2862089__nihms182856f1
figlink: /pmc/articles/PMC2862089/figure/F1/
number: F1
caption: Signal transduction pathways and crosstalk activated by insulin/IGF-1 receptor
  and GPCR systems. The binding of an agonist to its cognate GPCR induces Gq/PLC activation,
  hydrolysis of PIP2, generation of Ins(,,)P3 and Ca2+ mobilization as described in
  the text. DAG, the other product of PLC, activates novel PKCs (δ, ε, θ, η,)and,
  in synergy with Ca2+, conventional PKCs (α, β1, β2, γ). PKD (PKD1, PKD2 and PKD3)
  operate downstream of DAG and PKCs and lead via inactivation of the Ras/Raf inhibitor
  RIN1 to ERK pathway activation, potentiating signaling via mutated KRAS. Pathways
  activated by a typical Gq-coupled receptor are shown in blue. For the sake of clarity,
  stimulation of mTORC1 by ERK is not indicated in the scheme but is discussed in
  the text. Insulin/IGF induces PI3-kinase/Akt/TSC/Rheb/mTORC1 pathway, indicated
  in green. Positive crosstalk to GPCR-induced Ca2+signaling is indicated by the white
  broken line. A plausible target are Regulators of G proteins (RGS) which accelerate
  G protein inactivation by enhancing their GTPase activity. Negative feedback from
  S6K and mTORC1 on IRS is also indicated (white solid line). Metformin (chemical
  structure in the insert) is shown to activate AMPK with broken lines, because it
  does not interact directly with AMPK but increases the level of 5′AMP in the cell.
  AMPK opposes mTORC1 by phophorylating TSC2 and raptor, as indicated. AMPK also phosphorylates
  IRS (on Ser789) thereby moderating its activation when the negative feedback is
  removed by mTORC1 inhibition. See text for further details.Another phase I trial
  will examine side effects and best dose of metformin when given together with temsirolimus
  in treating patients with metastatic or unresectable solid tumor or lymphoma.
pmcid: PMC2862089
papertitle: 'Crosstalk between Insulin/IGF-1 and GPCR Signaling Systems: A Novel Target
  for the Anti-diabetic Drug Metformin in Pancreatic Cancer.'
reftext: Enrique Rozengurt, et al. Clin Cancer Res. ;16(9):2505-2511.
pmc_ranked_result_index: '59535'
pathway_score: 0.9693759
filename: nihms182856f1.jpg
figtitle: Signal transduction pathways and crosstalk activated by insulin/IGF-1 receptor
  and GPCR systems
year: ''
organisms:
- Homo sapiens
ndex: 48efa8e1-dec9-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2862089__nihms182856f1.html
  '@type': Dataset
  description: Signal transduction pathways and crosstalk activated by insulin/IGF-1
    receptor and GPCR systems. The binding of an agonist to its cognate GPCR induces
    Gq/PLC activation, hydrolysis of PIP2, generation of Ins(,,)P3 and Ca2+ mobilization
    as described in the text. DAG, the other product of PLC, activates novel PKCs
    (δ, ε, θ, η,)and, in synergy with Ca2+, conventional PKCs (α, β1, β2, γ). PKD
    (PKD1, PKD2 and PKD3) operate downstream of DAG and PKCs and lead via inactivation
    of the Ras/Raf inhibitor RIN1 to ERK pathway activation, potentiating signaling
    via mutated KRAS. Pathways activated by a typical Gq-coupled receptor are shown
    in blue. For the sake of clarity, stimulation of mTORC1 by ERK is not indicated
    in the scheme but is discussed in the text. Insulin/IGF induces PI3-kinase/Akt/TSC/Rheb/mTORC1
    pathway, indicated in green. Positive crosstalk to GPCR-induced Ca2+signaling
    is indicated by the white broken line. A plausible target are Regulators of G
    proteins (RGS) which accelerate G protein inactivation by enhancing their GTPase
    activity. Negative feedback from S6K and mTORC1 on IRS is also indicated (white
    solid line). Metformin (chemical structure in the insert) is shown to activate
    AMPK with broken lines, because it does not interact directly with AMPK but increases
    the level of 5′AMP in the cell. AMPK opposes mTORC1 by phophorylating TSC2 and
    raptor, as indicated. AMPK also phosphorylates IRS (on Ser789) thereby moderating
    its activation when the negative feedback is removed by mTORC1 inhibition. See
    text for further details.Another phase I trial will examine side effects and best
    dose of metformin when given together with temsirolimus in treating patients with
    metastatic or unresectable solid tumor or lymphoma.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAP2K1
  - AKT2
  - PRKAG3
  - PRKAA1
  - PIK3R3
  - PRKAG2
  - PLCE1
  - PRKAB1
  - NMUR1
  - PLCB4
  - PLCB3
  - PIK3CG
  - AKT1
  - PLCB1
  - PLCB2
  - PRKAA2
  - RAF1
  - AKT3
  - PLCD3
  - PRKCI
  - PRKCD
  - TSC2
  - PRKD3
  - PRKD1
  - TSC1
  - PLCD1
  - EIF4EBP1
  - IRS1
  - PRKCA
  - MAPK3
  - PRKCQ
  - PRKCG
  - PRKCH
  - RIN1
  - ARAF
  - PRKCZ
  - PLCZ1
  - RPTOR
  - PRKCB
  - PLCG1
  - BRAF
  - PRKAG1
  - PIK3R6
  - MAPK1
  - PRKAB2
  - PIK3CD
  - RICTOR
  - MAP2K2
  - PLCD4
  - PRKCE
  - PDK1
  - HRAS
  - IRS2
  - PIK3CA
  - PIK3CB
  - STK11
  - PLCG2
  - PIK3R5
  - MTOR
  - RHEB
  - PITX2
  - PIK3R4
  - NRAS
  - KRAS
  - METFORMIN
  - Metformin
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG3
  entrez: '53632'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA1
  entrez: '5562'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG2
  entrez: '51422'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCE1
  entrez: '51196'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB1
  entrez: '5564'
- word: GPCR
  symbol: GPC-R
  source: hgnc_alias_symbol
  hgnc_symbol: NMUR1
  entrez: '10316'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB4
  entrez: '5332'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB3
  entrez: '5331'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB1
  entrez: '23236'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB2
  entrez: '5330'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA2
  entrez: '5563'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD3
  entrez: '113026'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: TSC2
  symbol: TSC2
  source: hgnc_symbol
  hgnc_symbol: TSC2
  entrez: '7249'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: PKD
  symbol: PKD
  source: hgnc_alias_symbol
  hgnc_symbol: PRKD1
  entrez: '5587'
- word: TSC1
  symbol: TSC1
  source: hgnc_symbol
  hgnc_symbol: TSC1
  entrez: '7248'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD1
  entrez: '5333'
- word: 4E-BP1
  symbol: 4E-BP1
  source: hgnc_alias_symbol
  hgnc_symbol: EIF4EBP1
  entrez: '1978'
- word: IRS1/2
  symbol: IRS1
  source: hgnc_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: RIN1
  symbol: RIN1
  source: hgnc_symbol
  hgnc_symbol: RIN1
  entrez: '9610'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCZ1
  entrez: '89869'
- word: Raptor
  symbol: raptor
  source: hgnc_alias_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCG1
  entrez: '5335'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG1
  entrez: '5571'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB2
  entrez: '5565'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: Rictor
  symbol: RICTOR
  source: hgnc_symbol
  hgnc_symbol: RICTOR
  entrez: '253260'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD4
  entrez: '84812'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: PDK-1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: IRS1/2
  symbol: IRS2
  source: hgnc_symbol
  hgnc_symbol: IRS2
  entrez: '8660'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: LKB-1
  symbol: LKB1
  source: hgnc_alias_symbol
  hgnc_symbol: STK11
  entrez: '6794'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCG2
  entrez: '5336'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: Rheb
  symbol: RHEB
  source: hgnc_symbol
  hgnc_symbol: RHEB
  entrez: '6009'
- word: RGS
  symbol: RGS
  source: hgnc_prev_symbol
  hgnc_symbol: PITX2
  entrez: '5308'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
chemicals:
- word: METFORMIN
  source: MESH
  identifier: D008687
- word: Metformin
  source: MESH
  identifier: D008687
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC2862089__F1
redirect_from: /figures/PMC2862089__F1
figtype: Figure
---
